Baolingbao Biology Co.,Ltd. (SHE:002286)
8.09
+0.07 (0.87%)
Jul 15, 2026, 3:04 PM CST
Baolingbao Biology Revenue
Baolingbao Biology had revenue of 747.84M CNY in the quarter ending March 31, 2026, with 9.21% growth. This brings the company's revenue in the last twelve months to 2.81B, up 10.99% year-over-year. In the year 2025, Baolingbao Biology had annual revenue of 2.75B with 14.54% growth.
Revenue (ttm)
2.81B
Revenue Growth
+10.99%
P/S Ratio
1.08
Revenue / Employee
1.87M
Employees
1,505
Market Cap
3.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.75B | 349.27M | 14.54% |
| Dec 31, 2024 | 2.40B | -122.16M | -4.84% |
| Dec 31, 2023 | 2.52B | -188.83M | -6.96% |
| Jan 1, 2023 | 2.71B | -52.23M | -1.89% |
| Jan 1, 2022 | 2.76B | 710.40M | 34.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao Vland Biotech INC. | 1.40B |
| Beijing Kawin Technology Share-Holding | 1.30B |
| Pulike Biological Engineering | 1.06B |
| Guangdong VTR Bio-Tech | 842.50M |
| Hubei Goto Biopharm Group | 628.90M |
| Zhejiang Shouxiangu Pharmaceutical | 625.30M |
| Shanghai Model Organisms Center | 432.55M |
| Assure Tech (Hangzhou) | 407.16M |